Recursion Pharmaceuticals, Inc. announced in February 2024, the company named Kristen Rushton, M.B.A. as Chief Business Operations Officer. Ms. Rushton has worked at the company for over 6 years, previously serving as Senior Vice President of Business Operations. Prior to the company, Ms. Rushton worked at Myriad Genetics and Myrexis.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
8.6 USD | -0.46% | -2.71% | -12.78% |
12:12am | Recursion Pharmaceuticals Q1 Loss Widens, Revenue Rises | MT |
05-09 | Earnings Flash (RXRX) RECURSION PHARMACEUTICALS Reports Q1 Revenue $13.8M, vs. Street Est of $12.7M | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-12.78% | 2.06B | |
+3.91% | 108B | |
+10.87% | 104B | |
+1.28% | 22.33B | |
-13.14% | 22.19B | |
-7.05% | 18.69B | |
-38.36% | 17.74B | |
-10.66% | 17.64B | |
+3.75% | 14.05B | |
+36.70% | 12.51B |
- Stock Market
- Equities
- RXRX Stock
- News Recursion Pharmaceuticals, Inc.
- Recursion Pharmaceuticals, Inc. Appoints Kristen Rushton as Chief Business Operations Officer